Curaleaf Formally Launches $4-Per-Share Takeover Bid for Aurora Cannabis
Curaleaf Holdings has launched a $4-per-share takeover bid for Aurora Cannabis, offering 0.3463 subordinate voting shares and $0.75 cash per share. The bid, open until December 1, represents a 45% premium to Aurora's 30-day average price. Curaleaf expects $40M in annual cost savings and a combined revenue of $1.5B. Aurora's special committee has not yet recommended the offer.
How this was made

The 30-second read
Why it matters
The bid aims to create a $3 billion pro‑forma company with $1.5 billion revenue and $350 million EBITDA.
Market read
The announcement introduces a significant M&A event in the cannabis industry, affecting both U.S. and Canadian markets.
What to watch
Potential integration costs and cultural differences may erode projected synergies.
Background
Curaleaf and Aurora have been in talks; previous attempts failed, prompting a formal bid.
Market effects
Consolidation in the cannabis sector may pressure other fragmented players.
U.S. and Canadian cannabis markets could see valuation adjustments.
Creates a larger, diversified global cannabis platform with cross‑border reach.
Counterpoint
Deal could face regulatory hurdles and financing challenges, risking a collapse.
Key entities
- ExecutiveBoris Jordan
Chairman and CEO of Curaleaf, leading the acquisition effort.
- CommitteeAurora Special Committee
Body reviewing the takeover proposal on behalf of Aurora shareholders.




